Neoleukin Therapeutics (NLTX) Q2 2023 Earnings

10AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.3
-0.21
-0.13
-0.04

Details

Expected EPS
-0.04
Actual EPS
-0.04
Surprise EPS
0
Surprise Percent
+0%

Description

Neoleukin Therapeutics (NLTX) has reported earnings of -0.04 per share for Q2 2023.

0 Comments

Share your thoughts